New York lawmakers are expected to leave Albany this week without passing legislation that would bar drug manufacturers and pharmacy [...] …
Month: June 2024
Drugmaker Novartis recently filed the second lawsuit that seeks to block implementation and enforcement of a recently enacted Mississippi law [...] …
Bristol Myers Squibb (BMS) announced updates to its conditions on pharmaceutical sales involving contract pharmacies, requiring registered sites to be [...] …
Swedish biopharmaceutical company Sobi announced this week that beginning July 1 it will implement 340B contract pharmacy restrictions, making the [...] …
![img](https://340breport.com/wp-content/uploads/2023/03/340B-expert-tip-logo-final.png)
SPONSORED CONTENT
![img](https://340breport.com/wp-content/uploads/2023/03/340B-expert-tip-sidearrow-logo-final.png)
TIP: Don’t assume your contract pricing is correct on every account just because it’s correct on one account.
340B hospitals need new transparency requirements and program eligibility rules to ensure the sustainability of the program, Republican lawmakers said [...] …
A key House subcommittee oversight hearing today on the 340B program will include a witness who previously said Congress should [...] …
Vertex Pharmaceuticals has become the 33rd drugmaker to place 340B contract pharmacy restrictions, but the new policy exempts all six [...] …
SPONSORED CONTENT
All entities who participate in the 340B program are subject to an Office of Pharmacy Affairs (OPA) audit regardless of entity type, size or volume of transactions. For the last five years, HRSA’s OPA has been completing approximately 200 audits a year and
…
An influential drug industry group and a major drugmaker each filed lawsuits challenging West Virginia’s 340B contract pharmacy access law [...] …